CN109295140B - 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 - Google Patents
一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 Download PDFInfo
- Publication number
- CN109295140B CN109295140B CN201811231748.7A CN201811231748A CN109295140B CN 109295140 B CN109295140 B CN 109295140B CN 201811231748 A CN201811231748 A CN 201811231748A CN 109295140 B CN109295140 B CN 109295140B
- Authority
- CN
- China
- Prior art keywords
- collagen
- bladder
- dipeptidyl peptidase
- nibea
- japonica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000480037 Argyrosomus japonicus Species 0.000 title claims abstract description 53
- 102000008186 Collagen Human genes 0.000 title claims abstract description 53
- 108010035532 Collagen Proteins 0.000 title claims abstract description 53
- 229920001436 collagen Polymers 0.000 title claims abstract description 51
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 33
- 210000004712 air sac Anatomy 0.000 title claims abstract description 26
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 title claims abstract description 25
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 title claims abstract description 23
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 230000009182 swimming Effects 0.000 claims abstract description 49
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 229940088598 enzyme Drugs 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 11
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 claims abstract description 9
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 claims abstract description 9
- 238000012216 screening Methods 0.000 claims abstract description 7
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 6
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 6
- 229940111202 pepsin Drugs 0.000 claims abstract description 6
- 238000009210 therapy by ultrasound Methods 0.000 claims description 25
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 17
- 239000002608 ionic liquid Substances 0.000 claims description 15
- 102000035195 Peptidases Human genes 0.000 claims description 11
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 11
- 238000004108 freeze drying Methods 0.000 claims description 11
- 235000019419 proteases Nutrition 0.000 claims description 11
- 230000000813 microbial effect Effects 0.000 claims description 10
- 230000004044 response Effects 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000000376 reactant Substances 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- -1 bisimidazole hydroxide salt Chemical class 0.000 claims description 6
- 238000005238 degreasing Methods 0.000 claims description 6
- 230000000415 inactivating effect Effects 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 239000006227 byproduct Substances 0.000 abstract description 3
- 239000003112 inhibitor Substances 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 abstract description 2
- 201000001421 hyperglycemia Diseases 0.000 abstract description 2
- 238000000751 protein extraction Methods 0.000 abstract description 2
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 abstract 1
- 241000269821 Scombridae Species 0.000 abstract 1
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 abstract 1
- 235000020640 mackerel Nutrition 0.000 abstract 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 7
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 7
- 102100040918 Pro-glucagon Human genes 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000347391 Umbrina cirrosa Species 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000007872 degassing Methods 0.000 description 3
- 230000003544 deproteinization Effects 0.000 description 3
- 239000000859 incretin Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LGWQQSRBCPQEER-JEDNCBNOSA-N [N+](=O)([O-])C1=CC=C(N)C=C1.NCC(=O)N1[C@@H](CCC1)C(=O)O Chemical compound [N+](=O)([O-])C1=CC=C(N)C=C1.NCC(=O)N1[C@@H](CCC1)C(=O)O LGWQQSRBCPQEER-JEDNCBNOSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811231748.7A CN109295140B (zh) | 2018-10-22 | 2018-10-22 | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811231748.7A CN109295140B (zh) | 2018-10-22 | 2018-10-22 | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109295140A CN109295140A (zh) | 2019-02-01 |
CN109295140B true CN109295140B (zh) | 2022-01-18 |
Family
ID=65157599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811231748.7A Active CN109295140B (zh) | 2018-10-22 | 2018-10-22 | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109295140B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109824774B (zh) * | 2019-03-18 | 2020-11-20 | 时代生物科技(深圳)有限公司 | 一种回收高活性肽的方法 |
CN114957450B (zh) * | 2022-05-31 | 2023-09-22 | 甘肃农业大学 | 胶原基dpp-iv抑制肽的制备方法及胶原基dpp-iv抑制肽 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702346A (zh) * | 2012-06-20 | 2012-10-03 | 江南大学 | 一种从鱼皮中提取酸溶性胶原蛋白的方法及所得到的产品 |
CN103451258A (zh) * | 2013-06-19 | 2013-12-18 | 浙江海洋学院 | 具有高抗疲劳活性的梅鱼鱼鳔胶原蛋白的制备工艺 |
CN103571903A (zh) * | 2013-10-15 | 2014-02-12 | 江苏科技大学 | 利用超声波-离子液体耦合制备蚕蛹源ace抑制肽的方法 |
WO2014199780A1 (ja) * | 2013-06-12 | 2014-12-18 | マルハニチロ株式会社 | ジペプチジルペプチダーゼiv(dppiv)阻害ペプチド化合物、それを含有する組成物、及びその製造方法 |
CN104230813A (zh) * | 2014-09-05 | 2014-12-24 | 河南师范大学 | 一类peg功能化的双咪唑阳离子温控离子液体及其制备方法和应用 |
CN105219827A (zh) * | 2015-11-10 | 2016-01-06 | 浙江海洋学院 | 鱼鳔胶原蛋白多功能肽的制备方法 |
CN105254737A (zh) * | 2015-11-10 | 2016-01-20 | 浙江海洋学院 | 鱼鳔胶原抗氧化抗疲劳蛋白肽 |
CN105410945A (zh) * | 2015-11-10 | 2016-03-23 | 浙江海洋学院 | 鱼鳔胶原蛋白肽的用途 |
CN106520874A (zh) * | 2016-11-07 | 2017-03-22 | 中国农业大学 | 一种具有降血糖和抗氧化功能的鱼鳔蛋白肽及其制备方法 |
CN107141336A (zh) * | 2017-05-16 | 2017-09-08 | 青海国肽生物科技有限公司 | 具有dpp‑iv抑制活性的牦牛骨蛋白肽及制备方法 |
CN107266548A (zh) * | 2017-07-28 | 2017-10-20 | 浙江理工大学 | 一种利用离子液体和蛋白酶提取柞蚕丝丝素蛋白的方法 |
CN107586818A (zh) * | 2017-09-11 | 2018-01-16 | 浙江海洋大学 | 一种日本黄姑鱼鱼皮胶原蛋白的提取方法及应用 |
CN107586331A (zh) * | 2017-09-11 | 2018-01-16 | 浙江海洋大学 | 一种日本黄姑鱼鱼鳔胶原蛋白的提取方法及应用 |
-
2018
- 2018-10-22 CN CN201811231748.7A patent/CN109295140B/zh active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702346A (zh) * | 2012-06-20 | 2012-10-03 | 江南大学 | 一种从鱼皮中提取酸溶性胶原蛋白的方法及所得到的产品 |
WO2014199780A1 (ja) * | 2013-06-12 | 2014-12-18 | マルハニチロ株式会社 | ジペプチジルペプチダーゼiv(dppiv)阻害ペプチド化合物、それを含有する組成物、及びその製造方法 |
CN103451258A (zh) * | 2013-06-19 | 2013-12-18 | 浙江海洋学院 | 具有高抗疲劳活性的梅鱼鱼鳔胶原蛋白的制备工艺 |
CN103571903A (zh) * | 2013-10-15 | 2014-02-12 | 江苏科技大学 | 利用超声波-离子液体耦合制备蚕蛹源ace抑制肽的方法 |
CN104230813A (zh) * | 2014-09-05 | 2014-12-24 | 河南师范大学 | 一类peg功能化的双咪唑阳离子温控离子液体及其制备方法和应用 |
CN105254737A (zh) * | 2015-11-10 | 2016-01-20 | 浙江海洋学院 | 鱼鳔胶原抗氧化抗疲劳蛋白肽 |
CN105219827A (zh) * | 2015-11-10 | 2016-01-06 | 浙江海洋学院 | 鱼鳔胶原蛋白多功能肽的制备方法 |
CN105410945A (zh) * | 2015-11-10 | 2016-03-23 | 浙江海洋学院 | 鱼鳔胶原蛋白肽的用途 |
CN106520874A (zh) * | 2016-11-07 | 2017-03-22 | 中国农业大学 | 一种具有降血糖和抗氧化功能的鱼鳔蛋白肽及其制备方法 |
CN107141336A (zh) * | 2017-05-16 | 2017-09-08 | 青海国肽生物科技有限公司 | 具有dpp‑iv抑制活性的牦牛骨蛋白肽及制备方法 |
CN107266548A (zh) * | 2017-07-28 | 2017-10-20 | 浙江理工大学 | 一种利用离子液体和蛋白酶提取柞蚕丝丝素蛋白的方法 |
CN107586818A (zh) * | 2017-09-11 | 2018-01-16 | 浙江海洋大学 | 一种日本黄姑鱼鱼皮胶原蛋白的提取方法及应用 |
CN107586331A (zh) * | 2017-09-11 | 2018-01-16 | 浙江海洋大学 | 一种日本黄姑鱼鱼鳔胶原蛋白的提取方法及应用 |
Non-Patent Citations (5)
Title |
---|
‘智能型’大分子及其在生物技术中的应用;房喻等;《中国化学教学参考》;19991231;第103页左栏第4段 * |
Dissolution and regeneration of collagen fibers using ionic liquid;Zhuojun Meng等;《International Journal of Biological Macromolecules》;20120604;摘要,第442页右栏第3段-第445页左栏第1段 * |
Novel resorcinarene-based pH-triggered gelator;Scott R. Haines等;《CHEM. COMMUN》;20021028;摘要,结构1 * |
Temperature-responsive ionic liquid/water interfaces: relation between hydrophilicity of ions and dynamic phase change;Yuki kohno等;《Phys. Chem. Chem. Phys》;20120126;第5069页 Extraction of proteins using LCST-type phase transiton * |
具有温控两相性质的双阳离子型碱性离子液体的合成及其在有机反应中的应用;邢昙昙;《中国优秀硕士学位论文全文数据库 工程科技I辑》;20120715;第10-11页2 聚乙二醇桥连双阳离子型碱性离子液体的合成、表征 * |
Also Published As
Publication number | Publication date |
---|---|
CN109295140A (zh) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pal et al. | Sustainable valorisation of seafood by-products: Recovery of collagen and development of collagen-based novel functional food ingredients | |
Liang et al. | Effect of low‐frequency ultrasonic‐assisted enzymolysis on the physicochemical and antioxidant properties of corn protein hydrolysates | |
CN101979532B (zh) | 一种综合利用猪血的方法 | |
CN109735591B (zh) | 一种牛骨胶原蛋白肽及其生产方法 | |
US10575537B2 (en) | Saury Maillard peptide and its preparation method and application | |
CN109295140B (zh) | 一种日本黄姑鱼鱼鳔胶原蛋白源二肽基肽酶-iv抑制肽的制备方法 | |
CN108796017A (zh) | 牛骨肽及其酶解提取方法 | |
CN109897101B (zh) | 一种胶原蛋白三肽及其生产方法和应用 | |
CN109776652B (zh) | 鳕鱼皮寡肽及其分离纯化方法和在制备ɑ-葡萄糖苷酶抑制剂及抗Ⅱ型糖尿病药物中的应用 | |
CN105112478B (zh) | 一种鱿鱼皮活性多肽的制备方法 | |
CN105852134A (zh) | 一种海洋多肽-锌螯合物的制备方法与应用 | |
CN101225101A (zh) | 一种促肝细胞生长素溶液制备工艺 | |
CN108003219A (zh) | 一种能够提高碎米蛋白提取率且对其进行糖基化改性的方法 | |
CN107114793A (zh) | 一种综合利用鲟鱼骨制备钙和硫酸软骨素的方法 | |
CN109182435B (zh) | 一种生物源二肽基肽酶-iv抑制剂的制备方法 | |
CN112342260A (zh) | 一种利用脱脂南极磷虾粉制备降血糖肽的方法及其产品 | |
KR101021645B1 (ko) | 미백화된 오징어 콜라겐 유래 펩타이드의 제조방법 | |
WO2017215313A1 (zh) | 一种利用银杏果皮制备抗氧化肽的方法 | |
CN112501229A (zh) | 一种牛骨胶原肽的生产工艺 | |
CN102936611A (zh) | 一种从带鳞黑鲽鱼皮中提取的胶原及其应用 | |
CN108396054A (zh) | 一种酶解南极冰鱼制备低聚肽的方法 | |
KR20150067954A (ko) | 아임계수 및 초고압 효소 처리에 의해 태반을 저분자화하는 방법 | |
CN110643660B (zh) | 一种超声辅助驴皮蛋白酶解制备抗氧化肽的方法 | |
CN1584044A (zh) | 鹿角多肽或龟板多肽的制备方法 | |
Yang et al. | Angiotensin I converting enzyme inhibitory activity and antihypertensive effect in spontaneously hypertensive rats of cobia (Rachycentron canadum) head papain hydrolysate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Han Tao Inventor after: Tang Yunping Inventor after: Jiang Xiaoxia Inventor after: Ding Guofang Inventor after: Yu Fangmiao Inventor after: Yang Zuisu Inventor after: Huang Fangfang Inventor after: Chen Yan Inventor before: Tang Yunping Inventor before: Jiang Xiaoxia Inventor before: Ding Guofang Inventor before: Yu Fangmiao Inventor before: Yang Zuisu Inventor before: Huang Fangfang Inventor before: Chen Yan |
|
GR01 | Patent grant | ||
GR01 | Patent grant |